Surgical and pharmacological reassignment: influence on transsexual cardiovascular risk profile.

Marco M CicconeGiuseppe LoverroPietro ScicchitanoMatteo LoverroGabriella RicciFrancesca ScaramuzziMichele GesualdoAnnapaola ZitoMarcello CampagnaMichele MoncelliVittorio NicolardiFabio MancaBarbara BoninfanteSanta CarbonaraFrancesca CorteseOrlando TodarelloCarlo Bettocchi

Published in: Internal medicine journal (2018)

Cardiovascular risk, which is expressed in terms of endothelial (FMD) and morphological (C-IMT) dysfunction, increases in subjects undergoing gonadectomy compared with those receiving cross-sex reassignment therapy alone.

Keyphrases

endothelial cells
oxidative stress
mesenchymal stem cells
cell therapy
bone marrow